| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |